A detailed history of Bayesian Capital Management, LP transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 11,722 shares of VERA stock, worth $499,357. This represents 0.06% of its overall portfolio holdings.

Number of Shares
11,722
Holding current value
$499,357
% of portfolio
0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$34.09 - $46.71 $399,602 - $547,534
11,722 New
11,722 $517,000
Q1 2024

May 15, 2024

BUY
$14.91 - $49.14 $200,122 - $659,557
13,422 New
13,422 $578,000

Others Institutions Holding VERA

About Vera Therapeutics, Inc.


  • Ticker VERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,042,300
  • Market Cap $1.15B
  • Description
  • Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...
More about VERA
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.